GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
10.8478 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.78145 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.67539 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, PDE10A, PDE3A, PDE3B, PPARA, XDH |
7.65964 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, PDE3A, PPARA |
6.84612 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AR, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, MMP2, MMP9, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
6.4685 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HSD11B1, HSD17B1, HTR1A, HTR2A, OPRK1 |
6.18119 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
6.06797 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.88228 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, F10, FABP3, FABP4, HCAR2, HSD11B1, HSD17B1, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, PPARA, XDH |
5.82849 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.82849 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.82849 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.7268 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, MMP2, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
5.66213 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.61725 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, NR3C1, OPRK1, OPRM1, PDE3A |
5.55426 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.3711 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.29793 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
5.18398 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
5.07485 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD17B1 |
5.0312 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, HTR2A, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
5.0312 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
4.83162 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HTR2A, NR3C1, OPRK1, OPRM1, PDE3A |
4.66829 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HTR1A, HTR2A, MMP9, OPRD1, OPRK1, OPRM1 |
4.65552 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.47495 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
4.43014 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, XDH |
4.40736 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, HCAR2, HTR2A, MMP9, OPRK1, OPRM1, XDH |
4.36793 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, HCAR2, HTR2A, MMP9, OPRK1, OPRM1, XDH |
4.34875 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, NR3C1, OPRK1, PDE3B, PPARA |
4.34745 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1 |
4.34745 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1 |
4.33592 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, FABP3, FABP4, FUT7, PDE3A, PPARA |
4.28436 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
4.10445 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.10445 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.04057 |
[BP] GO:0006690 |
icosanoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.94654 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, OPRM1, PPARA |
3.82958 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD11B1, HSD17B1 |
3.74645 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.62955 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, HTR7, OPRK1, OPRM1, PGR, PPARA |
3.6257 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AR, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B |
3.6077 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, HTR2A, OPRM1, PPARA |
3.58773 |
[BP] GO:0006631 |
fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
3.51572 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HTR2A |
3.45223 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, HCAR2, HTR1A, HTR2A, MMP9, OPRD1, OPRK1, OPRM1, PPARA |
3.45223 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.42184 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CA2, CYP1A1, DRD1, DRD2, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, PPARA |
3.37874 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.37628 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
3.32248 |
[BP] GO:0051930 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.28431 |
[BP] GO:0051931 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.28431 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A |
3.28287 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.25796 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AR, BCL2, CYP1A1, CYP1B1, DRD1, FABP4, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B |
3.25486 |
[BP] GO:0033993 |
response to lipid
|
AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, NR3C1, OPRK1, OPRM1 |
3.23576 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CSNK2A1, CYP1B1, DRD2, FABP3, HTR1A, HTR2A, MMP2, MMP9, OPRM1, PGR, XDH |
3.16693 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, F10, FABP3, HCAR2, HTR1A, HTR2A, MMP1, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PGR, PPARA, XDH |
3.16491 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, MMP9 |
3.152 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.12939 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7, PDE3A |
3.12939 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR2A, HTR7 |
3.12433 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HTR1A, MMP1, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PGR, PPARA, SENP6, XDH |
3.09347 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HCAR2, HTR2A, OPRK1 |
3.08882 |
[BP] GO:0007267 |
None
|
ADORA1, AR, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.99941 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.97783 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA |
2.97342 |
[BP] GO:0007631 |
None
|
DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.973 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, MMP2, MMP9, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PGR, PPARA, SIGMAR1 |
2.96514 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, OPRK1 |
2.94223 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.91898 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA |
2.91612 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.91612 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.91612 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.88422 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, PDE10A, PDE3A, PDE3B, XDH |
2.85766 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7 |
2.84288 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, HTR1A |
2.82218 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2 |
2.7976 |
[BP] GO:0072523 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.78551 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
2.78551 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.77174 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, OPRD1, OPRK1 |
2.77174 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, HTR1A, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
2.73732 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PDE3B, PPARA |
2.73603 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, OPRD1, PPARA |
2.73412 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.73124 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.73124 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.71576 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HTR1A |
2.70643 |
[BP] GO:0023052 |
None
|
ADORA1, AR, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.70192 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.69244 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AR, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, F10, FABP3, FABP4, HTR1A, HTR2A, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
2.69197 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.68752 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.68752 |
[BP] GO:0007154 |
None
|
ADORA1, AR, BCL2, DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PGR |
2.67826 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, HTR2A |
2.67826 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, HTR2A |
2.67826 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, HTR1A, HTR2A, MMP9, OPRD1, OPRK1, OPRM1, PPARA |
2.66099 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AR, BCL2, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FABP3, FABP4, FUT7, HSD17B1, HTR1A, MMP1, MMP2, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PGR, PPARA, SENP6, XDH |
2.65815 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A |
2.64811 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, F10, FABP3, FABP4, HCAR2, HTR1A, HTR2A, MMP1, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PGR, PPARA, XDH |
2.63934 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7, PDE3A |
2.61746 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2 |
2.6073 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, HCAR2, HTR1A, HTR2A, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, XDH |
2.59006 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.58623 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, XDH |
2.58518 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.57044 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.57044 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
2.5573 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.5573 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1 |
2.54576 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.54405 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.54405 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, HCAR2, HTR1A, HTR2A, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, XDH |
2.53344 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.50973 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP2A6, PDE10A, PDE3A, PDE3B, XDH |
2.50973 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, AR, BCL2, DRD1, DRD2, FABP3, HTR2A, MMP9, OPRD1, OPRK1, OPRM1, XDH |
2.50973 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, AR, BCL2, DRD1, DRD2, FABP3, HTR2A, MMP9, OPRD1, OPRK1, OPRM1, XDH |
2.50973 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, CYP1B1, DRD1, MMP2, MMP9, NR3C1, OPRK1, PDE3A, PDE3B |
2.50721 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA |
2.50721 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, HTR1A, HTR2A |
2.49278 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.48355 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AR, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, F10, FABP4, HTR1A, HTR2A, HTR7, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PPARA |
2.48355 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
2.48355 |
[BP] GO:0050995 |
None
|
ADORA1, HCAR2, PDE3B |
2.4813 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HTR1A, HTR2A, HTR7 |
2.47764 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.42649 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.39146 |
[BP] GO:0032787 |
None
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
2.39146 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.39146 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR7 |
2.39146 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR7 |
2.39146 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.39146 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, HTR2A, MMP9 |
2.38352 |
[BP] GO:0031644 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
2.38352 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AR, CYP1A1, CYP1B1, DRD1, NR3C1, OPRM1, PDE3A |
2.37201 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, FABP3, OPRD1, PPARA, SIGMAR1 |
2.36742 |
[BP] GO:0010959 |
None
|
ADORA1, BCL2, DRD1, DRD2, HTR2A, OPRD1, OPRK1 |
2.34777 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, BCL2, CYP1B1, DRD2, F10, HTR2A, OPRK1, OPRM1, XDH |
2.34029 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.33139 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33139 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, NR3C1, OPRK1, OPRM1 |
2.33139 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, HCAR2, HTR2A, PDE3B, PPARA |
2.29787 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AR, BCL2, CSNK2A1, CYP1B1, DRD2, F10, HTR2A, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, XDH |
2.27802 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A |
2.27802 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA |
2.2665 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.22455 |
[BP] GO:0014059 |
None
|
DRD2, HTR2A, OPRK1 |
2.22455 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, HCAR2, HTR2A, OPRD1, OPRK1, OPRM1 |
2.18783 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2A, HTR7 |
2.1823 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR3C1, NR3C2, PGR, PPARA |
2.16627 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, OPRK1, OPRM1 |
2.15585 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1 |
2.15585 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.15585 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.15585 |
[BP] GO:0009154 |
None
|
PDE10A, PDE3A, PDE3B |
2.15585 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.15585 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.15585 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.15585 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.15585 |
[BP] GO:0009261 |
None
|
PDE10A, PDE3A, PDE3B |
2.12334 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.12334 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.12157 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA |
2.10927 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AR, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B |
2.10333 |
[BP] GO:0043278 |
None
|
DRD2, OPRK1, OPRM1 |
2.09928 |
[BP] GO:0014072 |
None
|
DRD2, OPRK1, OPRM1 |
2.09928 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A |
2.09928 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, AR, BCL2, CYP1B1, DRD2, FABP3, OPRM1, XDH |
2.09245 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, OPRK1, OPRM1 |
2.08305 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
2.06642 |
[BP] GO:0046058 |
None
|
PDE10A, PDE3A, PDE3B |
2.06642 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.0581 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, MMP9, OPRK1 |
2.03789 |
[BP] GO:0019933 |
None
|
DRD1, DRD2, OPRM1, PDE3A |
2.03778 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DRD1, DRD2, HTR2A, MMP9, OPRK1, OPRM1, PDE3B, XDH |
2.02891 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.02891 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.02891 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.02891 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.02891 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DRD1, DRD2, HTR2A, MMP9, OPRK1, OPRM1, PDE3B, XDH |
2.02052 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1 |
2.02052 |
[BP] GO:0007626 |
None
|
DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.01114 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PPARA |
2.01114 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, AR, BCL2, DRD1, DRD2, FABP4, HTR2A, MMP9, OPRD1, OPRK1, OPRM1, PPARA, XDH |
2.01058 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, F10, FABP3, HTR2A, MMP9, OPRD1, OPRM1, PPARA, SIGMAR1, XDH |
2.00283 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, HSD11B1, NR3C2, SIGMAR1 |
3.09134 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, F10, HSD11B1, NR3C2, SIGMAR1 |
2.51232 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, AR, BCL2, CA12, CA14, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FUT7, HCAR2, HSD11B1, HTR1A, HTR2A, HTR7, MMP2, NR3C2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PGR, SIGMAR1 |
2.28198 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AR, BCL2, CA1, CA2, CA5A, CA5B, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HTR2A, MMP2, MMP9, NR3C1, NR3C2, OPRM1, PDE10A, PDE3A, PDE3B, PGR, SENP6, SIGMAR1, XDH |
2.16236 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, BCL2, CA12, CA14, CA2, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FUT7, HCAR2, HSD11B1, HTR1A, HTR2A, HTR7, NR3C2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SIGMAR1 |
1.87205 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
15.4972 |
[MF] GO:0046914 |
transition metal ion binding
|
AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, XDH |
12.4828 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
10.0294 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
8.94042 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.94042 |
[MF] GO:0043169 |
cation binding
|
ACHE, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, HTR1A, HTR2A, HTR7, MMP1, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PGR, PPARA, XDH |
8.59333 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.31644 |
[MF] GO:0043167 |
ion binding
|
ACHE, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, F10, FABP3, FABP4, HSD17B1, HTR1A, HTR2A, HTR7, MMP1, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PGR, PPARA, XDH |
6.90845 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA |
6.62896 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
5.88228 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.74908 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.61725 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.3923 |
[MF] GO:0005506 |
iron ion binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
5.2252 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.80169 |
[MF] GO:0046872 |
metal ion binding
|
AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, MMP1, MMP2, MMP9, NR3C1, NR3C2, PDE10A, PDE3A, PDE3B, PGR, PPARA, XDH |
4.73606 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR7 |
4.69358 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, SIGMAR1 |
4.66829 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.65983 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.46378 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
4.19551 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, SIGMAR1 |
4.04323 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, SIGMAR1 |
3.86903 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRM1 |
3.83979 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA |
3.79457 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, NR3C1, NR3C2, OPRD1, OPRK1, OPRM1, PGR, PPARA, SIGMAR1 |
3.52256 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.25486 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, FUT7, HSD11B1, HSD17B1, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SENP6, XDH |
3.20315 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, XDH |
3.19974 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR7 |
3.16491 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR7 |
3.16491 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR7, OPRM1 |
3.152 |
[MF] GO:0005496 |
steroid binding
|
AR, HSD17B1, NR3C1, NR3C2, PGR |
3.13777 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, XDH |
3.03424 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.91612 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.88422 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.88422 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.84288 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR7 |
2.73603 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2A, HTR7 |
2.63417 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.4813 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR7 |
2.39146 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.39146 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR7 |
2.39146 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.34859 |
[MF] GO:0008289 |
lipid binding
|
AR, F10, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA |
2.17578 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, NR3C1 |
2.12211 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
2.10284 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, DRD1, DRD2, HCAR2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
2.10284 |
[MF] GO:0008081 |
None
|
ADORA1, PDE10A, PDE3A, PDE3B |
2.03778 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02891 |
[MF] GO:0008144 |
drug binding
|
ACHE, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, HTR2A, PDE10A, PPARA, SIGMAR1 |
2.01058 |